INTRODUCTION
Abnormalities of serum enzyme activities may be associated with hyperthyroidism but the frequency with which this is seen is uncertain.F The most commonly described finding is a raised alkaline phosphatase activity but serum activity of transaminases may also be increased.' These changes are usually incidental. We now report a case of Graves' disease presenting with profound cholestatic jaundice in a 31-year old female.
CASE HISTORY
JB, a 31-year old woman, presented with a 10day history of diarrhoea, vomiting, dark urine, pale stools and generalized itch. She also complained of shortness of breath on exercise, fatigue, night sweats and vague abdominal and joint pains. She was taking the oral contraceptive pill and smoked 20 cigarettes per day. She had not been abroad recently and there was no history of exposure to illness, blood transfusion, alcohol ingestion or intravenous drug abuse.
She had been admitted briefly to hospital 8 months previously following a l-rnonth history of diarrhoea, vomiting and generalized weakness.
On examination, she was jaundiced and clearly in some distress. She weighed 60 kg. Her pulse rate was 100/min and blood pressure 130180 mmHg. She had a fine tremor of her outstretched hands and a smooth goitre. Her temperature was 36·8°C and bilirubin was detected in her urine.
Liver function test results were: bilirubin 248 /lmol/L ( < 20), alanine transaminase activity 36 U/L (5-38), alkaline phosphatase activity 507 UIL (3D-I15) and y glutamyl transferase activity 16 U/L (5-30). A raised alkaline phosphatase with a y glutamyl transferase within the reference range is unusual but has been described in other liver conditions.' The serum alkaline phosphatase was subsequently shown to Correspondence: Miss S C Barnes. E-mail: sophiebarnes@hotmail.com be mostly of hepatic origin (total activity 489 UIL, liver 353 U/L and bone 136 U/L). Haematology results were: haemoglobin 12·9 g/dL (11-15), mean cell volume (MCV) 81·2 fL (82-99), white blood cells (WBC) 4·76 10 9/L (4-11), platelets 229 10 9/L (130-400), erythrocyte sedimentation rate (ESR) 4mm/h and International Normalized Ratio (lNR) 1. Histological examination of a liver biopsy demonstrated mainly intracanalicular and marked centrilobular cholestasis. The appearance was of cholestasis with minimal parenchymal changes and no significant portal abnormalities. There was no excess of fibrous tissue, iron or copper in the liver biopsy. Abdominal ultrasound did not show any abnormalities in the parenchyma or hepatic/ pancreatic ducts, and gallstones were not detected. Hepatitis B antigen and antibody, hepatitis C antibody and hepatitis A IgM antibody were all negative, as were urine and faeces cultures. Biochemical investigation for Wilson's disease and n-I antitrypsin deficiency showed serum copper 55·3/lmol/L (13-27), serum caeruloplasmin 1·16 giL (0' 25--0'63) and serum rx-l antitrypsin 1-45g/L (1·1-2·1). A penicillamine challenge test was carried out because of the high serum copper and caeruloplasmin concentrations. A normal result was obtained, thereby excluding Wilson's disease.
The initial diagnosis of primary liver disease was revised when thyroid function tests were done. Results of these were: free thyroxine (T 4 ) 97·0 pmol/L (9'8-23'0), free triiodothyronine (T 3 ) 27'9pmol/L (3·0-6'7) and thyroid stimula~ ing hormone (TSH) < 0·02 U/L (0'3-3'5). Antimitochondrial antibodies were not present but serum antibodies to thyroglobulin, thyroid microsomes, gastric parietal cell and smooth muscle were present in high titre, consistent with a diagnosis of Graves' disease.
The patient was started on 40 mg prednisolone because of the original diagnosis of primary liver disease but this was changed to 40 mg carbimazole per day. This led to resolution of her thyroid and liver function tests (Fig. 1) . Interestingly, although her serum alkaline phosphatase activity fell in response to steroid treatment, the patient's bilirubin concentration continued to rise until carbimazole treatment was started. She was biochemically euthyroid when she returned to the outpatients' department 6 weeks after admission. Three and a half months after presentation, her serum alkaline phosphatase activity and bilirubin concentration had decreased to 108 U jL and 8 JlmoljL, respectively. This recovery in thyroid and liver function was accompanied by an increase in her weight. The patient stopped taking carbimazole 5 months later because she was concerned about a rash that had developed on treatment. Her serum free T 4 concentration increased and she became clinically hyperthyroid (TSH 0·01 UjL, free T 4 51'6pmoljL, free T 3 15'OpmoljL) with a rise in serum alkaline phosphatase activity to 176 U jL. She was started on 200 mg propylthiouracil per day and became euthyroid (TSH 0·02 UjL, free T 4 23·3 pmoljL, free T 3 5·OpmoljL). A similar temporal relationship between liver function tests and thyroid status was recently demonstrated in a case of hepatic granulomatous disease associated with Graves' disease." She remains well on maintenance propylthiouracil. The final diagnosis was Graves' disease with secondary cholestasis.
DISCUSSION
Although the association between thyrotoxicosis and an elevated serum alkaline phosphatase activity is well recognized, the association of Graves' disease and clinically evident cholestasis is much less common. However, Sola et al? demonstrated that histological evidence of cholestasis may be more common than is realized.
A case of primary biliary cirrhosis due to hyperthyroidism has been reported! but the absence of anti-mitochondrial antibodies was inconsistent with this diagnosis in our patient.
At least six mechanisms have been proposed for the association between liver and thyroid function. These include an increase in hepatic oxygen consumption owing to the hypermetabolic state without a concomitant increase in hepatic blood flow. This is proposed to lower oxygen tension in the lobular zones and interfere with bile transport.F' Alternatively, increased liver metabolism in response to thyroid hormones increases the rate of bile flow to the point of saturation. It seems unlikely, however, since the typical adult liver is only working at 1% of its total capacity. Cholestasis may also be caused by a direct toxic effect of thyroxine (in vitro studies have not supported this)? or a latent deficit of bilirubin-glucuronyl transferase (Gilbert's syndrome}. 5 Gilbert's syndrome was unlikely in our patient because most of her serum bilirubin was conjugated (direct bilirubin 262 Jlmol/L, total serum bilirubin 347 Jlmol/L).
Another suggestion is that interference in the fluidity of the canalicular membranes would affect the activity of the trans-membrane sodium-potassium ATPase. This has been shown to cause cholestatic jaundice as a result of toxicity with drugs such as chlorpromazine'' and ethinyl oestradiol." It is not clear if the oral contraceptive pill contributed to the cholestatic jaundice in this patient but she had stopped taking oral contraceptives prior to admission, so a relationship between this and the subsequent episode of cholestasis seems unlikely.
This case illustrates how hyperthyroidism may present in a dramatically atypical manner.
